318 related articles for article (PubMed ID: 32218692)
1. Expression of CD4+CD25+CD127
Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
[No Abstract] [Full Text] [Related]
2. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
Feng X; Li B; Ye H; Long D
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
[TBL] [Abstract][Full Text] [Related]
3. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
4. Peripheral CD4
Qiu J; Shi W; Zhang J; Gao Q; Feng L; Zhuang Z
BMC Gastroenterol; 2023 May; 23(1):168. PubMed ID: 37210494
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency and FOXP3 expression of human CD8
Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
[TBL] [Abstract][Full Text] [Related]
6. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
8. [Study on expressions of CD25 and CD127 in CD4+ peripheral T lymphocytes of patients with rheumatoid arthritis].
Huang ZX; Zheng BR; Li TW; Lu YM; Gu JR; Han XY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2476-80. PubMed ID: 20137434
[TBL] [Abstract][Full Text] [Related]
9. Targeting cytokines secreted by CD4
Ke X; Shen L
Scand J Immunol; 2019 Feb; 89(2):e12736. PubMed ID: 30485902
[TBL] [Abstract][Full Text] [Related]
10. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ and CD4+CD2+high regulatory T cells in disseminated and localized forms of allergic contact dermatitis: relation to specific cytokines.
Reduta T; Stasiak-Barmuta A; Laudańska H
Folia Histochem Cytobiol; 2011; 49(2):255-62. PubMed ID: 21744325
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
Drennan S; Stafford ND; Greenman J; Green VL
Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
[TBL] [Abstract][Full Text] [Related]
15. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.
Klein S; Kretz CC; Krammer PH; Kuhn A
J Invest Dermatol; 2010 Feb; 130(2):492-9. PubMed ID: 19940860
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
Front Immunol; 2015; 6():49. PubMed ID: 25767469
[TBL] [Abstract][Full Text] [Related]
17. [Changes of CD4+CD25+ regulatory T cells, IL-10 and TGF-beta1 levels in peripheral blood in children with asthma].
Li M; Song L; Zhang JB; Fang J; Li L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):829-32. PubMed ID: 19849943
[TBL] [Abstract][Full Text] [Related]
18. Changes in CD4
Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L
Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815
[TBL] [Abstract][Full Text] [Related]
19. A modified flow cytometry method for objective estimation of human CD4
Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
[TBL] [Abstract][Full Text] [Related]
20. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
Yang XH; Liu BR; Jiang HC
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]